Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
The etiology of ring lesions on diffusion-weighted imaging.
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Perth scientists embark on stroke therapy approach
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
Intractable hiccup caused by spinal cord lesions in demyelination disease.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Retinal nerve fiber layer thickness in benign multiple sclerosis.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Effects of yoga interventions on fatigue: a meta-analysis.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Primary varicella zoster infection associated with fingolimod treatment.

Pages